Abstract
Background: Nitric oxide in exhaled air (FENO) is a marker of eosinophilic airway inflammation. A study was undertaken to determine whether FENO predicts asthma relapse in asymptomatic asthmatic children in whom inhaled corticosteroids are discontinued.
Methods: Forty children (21 boys) of mean age 12.2 years on a median dose of 400 µg budesonide or equivalent (range 100–400) were included. FENO was measured before and 2, 4, 12, and 24 weeks after withdrawal of steroids. A relapse was defined as more than one exacerbation per month, or need for ß agonist treatment on 4 days per week for at least 2 weeks, or diurnal peak flow variability of >20%. FENO measurements were performed online with an expiratory flow of 50 ml/s.
Results: Nine patients relapsed. Two and 4 weeks after withdrawal of steroids geometric mean FENO in children who were about to relapse was higher than in those who did not relapse: 35.3 ppb v 15.7 ppb at 2 weeks (ratio 2.3; 95% CI 1.2 to 4.1; p = 0.01) and 40.8 ppb v 15.9 ppb at 4 weeks (ratio 2.6; 95% CI 1.3 to 5.1). An FENO value of 49 ppb at 4 weeks after discontinuation of steroids had the best combination of sensitivity (71%) and specificity (93%) for asthma relapse.
Conclusion: FENO 2 and 4 weeks after discontinuation of steroids in asymptomatic asthmatic children may be an objective predictor of asthma relapse.
Full Text
The Full Text of this article is available as a PDF (110.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baraldi E., Azzolin N. M., Zanconato S., Dario C., Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997 Sep;131(3):381–385. doi: 10.1016/s0022-3476(97)80062-5. [DOI] [PubMed] [Google Scholar]
- Baraldi E., de Jongste J. C., European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force Measurement of exhaled nitric oxide in children, 2001. Eur Respir J. 2002 Jul;20(1):223–237. doi: 10.1183/09031936.02.00293102. [DOI] [PubMed] [Google Scholar]
- Barbee R. A., Murphy S. The natural history of asthma. J Allergy Clin Immunol. 1998 Oct;102(4 Pt 2):S65–S72. doi: 10.1016/s0091-6749(98)70006-5. [DOI] [PubMed] [Google Scholar]
- Beck-Ripp J., Griese M., Arenz S., Köring C., Pasqualoni B., Bufler P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J. 2002 Jun;19(6):1015–1019. doi: 10.1183/09031936.02.01582001. [DOI] [PubMed] [Google Scholar]
- Hamid Q., Springall D. R., Riveros-Moreno V., Chanez P., Howarth P., Redington A., Bousquet J., Godard P., Holgate S., Polak J. M. Induction of nitric oxide synthase in asthma. Lancet. 1993 Dec 18;342(8886-8887):1510–1513. doi: 10.1016/s0140-6736(05)80083-2. [DOI] [PubMed] [Google Scholar]
- Hoekstra M. O. Behandeling van astma bij kinderen; herziene richtlijnen van kinderlongartsen. Sectie Kinderlongziekten van de Nederlandse Vereniging voor Kindergeneeskunde. Ned Tijdschr Geneeskd. 1997 Nov 15;141(46):2223–2229. [PubMed] [Google Scholar]
- Jatakanon A., Kharitonov S., Lim S., Barnes P. J. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax. 1999 Feb;54(2):108–114. doi: 10.1136/thx.54.2.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jatakanon A., Lim S., Barnes P. J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med. 2000 Jan;161(1):64–72. doi: 10.1164/ajrccm.161.1.9809100. [DOI] [PubMed] [Google Scholar]
- Jones S. L., Kittelson J., Cowan J. O., Flannery E. M., Hancox R. J., McLachlan C. R., Taylor D. R. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001 Sep 1;164(5):738–743. doi: 10.1164/ajrccm.164.5.2012125. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Barnes P. J. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001 Jun;163(7):1693–1722. doi: 10.1164/ajrccm.163.7.2009041. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Gonio F., Kelly C., Meah S., Barnes P. J. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J. 2003 Mar;21(3):433–438. doi: 10.1183/09031936.03.00066903a. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Yates D. H., Chung K. F., Barnes P. J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 1996 Feb;9(2):196–201. doi: 10.1183/09031936.96.09020196. [DOI] [PubMed] [Google Scholar]
- Leuppi J. D., Salome C. M., Jenkins C. R., Anderson S. D., Xuan W., Marks G. B., Koskela H., Brannan J. D., Freed R., Andersson M. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001 Feb;163(2):406–412. doi: 10.1164/ajrccm.163.2.9912091. [DOI] [PubMed] [Google Scholar]
- Lim S., Jatakanon A., John M., Gilbey T., O'connor B. J., Chung K. F., Barnes P. J. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999 Jan;159(1):22–30. doi: 10.1164/ajrccm.159.1.9706006. [DOI] [PubMed] [Google Scholar]
- Silkoff P. E., McClean P., Spino M., Erlich L., Slutsky A. S., Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest. 2001 May;119(5):1322–1328. doi: 10.1378/chest.119.5.1322. [DOI] [PubMed] [Google Scholar]
- Strachan D. P. The epidemiology of childhood asthma. Allergy. 1999;54 (Suppl 49):7–11. doi: 10.1111/j.1398-9995.1999.tb04381.x. [DOI] [PubMed] [Google Scholar]
- Verberne A. A., Frost C., Duiverman E. J., Grol M. H., Kerrebijn K. F. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med. 1998 Jul;158(1):213–219. doi: 10.1164/ajrccm.158.1.9706048. [DOI] [PubMed] [Google Scholar]